Vitamin K2 Induces Mitochondria-Related Apoptosis in Human Bladder Cancer Cells Via ROS and JNK/p38 MAPK Signal Pathways

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2016 Aug 30

PMID 27570977

Citations 29

Authors

Fengsen Duan

Yuejin Yu

Rijian Guan

Zhiliang Xu

Huageng Liang

Ling Hong

Affiliations

Soon will be listed here.

Abstract

The effects of vitamin K2 on apoptosis in a variety of cancer cells have been well established in previous studies. However, the apoptotic effect of vitamin K2 on bladder cancer cells has not been evaluated. The aim of this study is to examine the apoptotic activity of Vitamin K2 in bladder cancer cells and investigate the underlying mechanism. In this study, Vitamin K2 induced apoptosis in bladder cancer cells through mitochondria pathway including loss of mitochondria membrane potential, cytochrome C release and caspase-3 cascade. Furthermore, the phosphorylation of c-Jun N-terminal kinase (JNK) and p38 MAPK was detected in Vitamin K2-treated cells and both SP600125 (an inhibitor of JNK) and SB203580 (an inhibitor of p38 MAPK) completely abolished the Vitamin K2-induced apoptosis and loss of mitochondria membrane potential. Moreover, the generation of reactive oxygen species (ROS) was detected in bladder cancer cells, upon treatment of vitamin K2 and the anti-oxidant N-acetyl cysteine (NAC) almost blocked the Vitamin K2-triggered apoptosis, loss of mitochondria membrane potential and activation of JNK and p38 MAPK. Taken together, these findings revealed that Vitamin K2 induces apoptosis in bladder cancer cells via ROS-mediated JNK/p38 MAPK and Mitochondrial pathways.

Citing Articles

C-reactive protein-induced injury in -infected lung epithelial cells is mediated by the P38 MAPK/mitochondrial apoptosis pathway.

Li L, Zhang Y, Zhao L, Shi Y Microbiol Spectr. 2025; 13(3):e0162624.

PMID: 39932324 PMC: 11878036. DOI: 10.1128/spectrum.01626-24.

Beyond the Coagulation Cascade: Vitamin K and Its Multifaceted Impact on Human and Domesticated Animal Health.

Sadler R, Shoveller A, Shandilya U, Charchoglyan A, Wagter-Lesperance L, Bridle B Curr Issues Mol Biol. 2024; 46(7):7001-7031.

PMID: 39057059 PMC: 11276079. DOI: 10.3390/cimb46070418.

Vitamin K2 sensitizes the efficacy of venetoclax in acute myeloid leukemia by targeting the NOXA-MCL-1 pathway.

Tauchi T, Moriya S, Okabe S, Kazama H, Miyazawa K, Takano N PLoS One. 2024; 19(7):e0307662.

PMID: 39052583 PMC: 11271855. DOI: 10.1371/journal.pone.0307662.

Vitamin K2 in Health and Disease: A Clinical Perspective.

Zhang T, OConnor C, Sheridan H, Barlow J Foods. 2024; 13(11).

PMID: 38890875 PMC: 11172246. DOI: 10.3390/foods13111646.

Redox System and Oxidative Stress-Targeted Therapeutic Approaches in Bladder Cancer.

Dugbartey G, Relouw S, McFarlane L, Sener A Antioxidants (Basel). 2024; 13(3).

PMID: 38539821 PMC: 10967649. DOI: 10.3390/antiox13030287.

References

Latimer H, Veal E . Peroxiredoxins in Regulation of MAPK Signalling Pathways; Sensors and Barriers to Signal Transduction. Mol Cells. 2016; 39(1):40-5. PMC: 4749872. DOI: 10.14348/molcells.2016.2327. View

Juffs H, Moore M, Tannock I . The role of systemic chemotherapy in the management of muscle-invasive bladder cancer. Lancet Oncol. 2002; 3(12):738-47. DOI: 10.1016/s1470-2045(02)00930-0. View

Yoshida T, Miyazawa K, Kasuga I, Yokoyama T, Minemura K, Ustumi K . Apoptosis induction of vitamin K2 in lung carcinoma cell lines: the possibility of vitamin K2 therapy for lung cancer. Int J Oncol. 2003; 23(3):627-32. View

Yaguchi M, Miyazawa K, Katagiri T, Nishimaki J, Kizaki M, Tohyama K . Vitamin K2 and its derivatives induce apoptosis in leukemia cells and enhance the effect of all-trans retinoic acid. Leukemia. 1997; 11(6):779-87. DOI: 10.1038/sj.leu.2400667. View

Miyazawa K, Yaguchi M, Funato K, Gotoh A, Kawanishi Y, Nishizawa Y . Apoptosis/differentiation-inducing effects of vitamin K2 on HL-60 cells: dichotomous nature of vitamin K2 in leukemia cells. Leukemia. 2001; 15(7):1111-7. DOI: 10.1038/sj.leu.2402155. View

Hafeez S, Huddart R . Selective organ preservation for the treatment of muscle-invasive transitional cell carcinoma of the bladder: a review of current and future perspectives. Expert Rev Anticancer Ther. 2014; 14(12):1429-43. DOI: 10.1586/14737140.2014.953938. View

Nakagawa K, Hirota Y, Sawada N, Yuge N, Watanabe M, Uchino Y . Identification of UBIAD1 as a novel human menaquinone-4 biosynthetic enzyme. Nature. 2010; 468(7320):117-21. DOI: 10.1038/nature09464. View

Feuerstein M, Goenka A . Quality of Life Outcomes for Bladder Cancer Patients Undergoing Bladder Preservation with Radiotherapy. Curr Urol Rep. 2015; 16(11):75. DOI: 10.1007/s11934-015-0547-1. View

Krilleke D, Ucur E, Pulte D, Schulze-Osthoff K, Debatin K, Herr I . Inhibition of JNK signaling diminishes early but not late cellular stress-induced apoptosis. Int J Cancer. 2003; 107(4):520-7. DOI: 10.1002/ijc.11331. View

10.

Stevenson S, Danzig M, Ghandour R, Deibert C, DeCastro G, Benson M . Cost-effectiveness of neoadjuvant chemotherapy before radical cystectomy for muscle-invasive bladder cancer. Urol Oncol. 2014; 32(8):1172-7. DOI: 10.1016/j.urolonc.2014.05.001. View

11.

Li S, Dong P, Wang J, Zhang J, Gu J, Wu X . Icariin, a natural flavonol glycoside, induces apoptosis in human hepatoma SMMC-7721 cells via a ROS/JNK-dependent mitochondrial pathway. Cancer Lett. 2010; 298(2):222-30. DOI: 10.1016/j.canlet.2010.07.009. View

12.

Yu J, Zhang L . PUMA, a potent killer with or without p53. Oncogene. 2009; 27 Suppl 1:S71-83. PMC: 2860432. DOI: 10.1038/onc.2009.45. View

13.

Xiong X, Liu J, Qiu X, Pan F, Yu S, Chen X . Piperlongumine induces apoptotic and autophagic death of the primary myeloid leukemia cells from patients via activation of ROS-p38/JNK pathways. Acta Pharmacol Sin. 2015; 36(3):362-74. PMC: 4349924. DOI: 10.1038/aps.2014.141. View

14.

Matsumoto K, Okano J, Nagahara T, Murawaki Y . Apoptosis of liver cancer cells by vitamin K2 and enhancement by MEK inhibition. Int J Oncol. 2006; 29(6):1501-8. View

15.

Park G, Kim Y, Lee H, Song H, Kim S, Cho D . Reactive oxygen species and p38 MAPK regulate Bax translocation and calcium redistribution in salubrinal-induced apoptosis of EBV-transformed B cells. Cancer Lett. 2011; 313(2):235-48. DOI: 10.1016/j.canlet.2011.09.011. View

16.

Zhang D, Armstrong J . Bax and the mitochondrial permeability transition cooperate in the release of cytochrome c during endoplasmic reticulum-stress-induced apoptosis. Cell Death Differ. 2006; 14(4):703-15. DOI: 10.1038/sj.cdd.4402072. View

17.

Hermans T, Mertens L, van Rhijn B . Re: Trends in the Use of Perioperative Chemotherapy for Localized and Locally Advanced Muscle-invasive Bladder Cancer: A Sign of Changing Tides. Eur Urol. 2016; 69(6):1156-7. DOI: 10.1016/j.eururo.2016.02.023. View

18.

Santabarbara-Ruiz P, Lopez-Santillan M, Martinez-Rodriguez I, Binagui-Casas A, Perez L, Milan M . ROS-Induced JNK and p38 Signaling Is Required for Unpaired Cytokine Activation during Drosophila Regeneration. PLoS Genet. 2015; 11(10):e1005595. PMC: 4619769. DOI: 10.1371/journal.pgen.1005595. View

19.

Yang C, Liao W, Wu Y, Murugan K, Chen C, Chao J . CR108, a novel vitamin K3 derivative induces apoptosis and breast tumor inhibition by reactive oxygen species and mitochondrial dysfunction. Toxicol Appl Pharmacol. 2013; 273(3):611-22. DOI: 10.1016/j.taap.2013.10.007. View

20.

Lamson D, Plaza S . The anticancer effects of vitamin K. Altern Med Rev. 2003; 8(3):303-18. View